Skip to content

COMPARISON OF EFFECTS OF GABAPENTIN AND CLONIDINE ON POST-OPERATIVE PAIN AND ANXIETY IN LUMBAR SPINAL SURGERY.

Gabpentin vs Clonidine for Post Operative Pain

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07297888
Enrollment
90
Registered
2025-12-22
Start date
2022-07-20
Completion date
2024-03-20
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Keywords

gabapentin, clonidine, pain

Brief summary

the investigators have tested whether gabapentin is superior to clonidine top decrease the post operative pain during spinal surgeries as a part of their thesis study. the investigators are registering this study post date as the student forgot by mistake to do so.

Interventions

DRUGGabapentin

comparison of both these drugs to decrease pain

Sponsors

Shri Guru Ram Rai Institute of Medical and Health Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

\- Eligible participants were aged 18-60 years, classified as ASA physical status I or II, and scheduled for one or two-level lumbar laminectomy.

Exclusion criteria

* Patients with psychiatric disorders, autoimmune diseases, local infection, BMI \>35, emergency procedures, tumour surgeries and the patients requiring the postoperative ventilation were excluded

Design outcomes

Primary

MeasureTime frameDescription
post operative pain1, 2, 4, 6, 8, 12, and 24 hours postoperatively.Pain was assessed using the Visual Analog Scale (VAS) score ranging from 0 to 10. 10 being the worst pain and 0 being No pain

Secondary

MeasureTime frameDescription
anxiety1, 2, 4, 6, 8, 12, and 24 hours postoperatively.anxiety was evaluated using Hamilton Anxiety Rating Scale (HAM-A). Each item is scored on a scale of 0 (not present) to 4 (severe), with a total score range of 0-56, where \<17 indicates mild severity, 18-24 mild to moderate severity and 25-30 moderate to severe.

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026